April 24, 2010

Chantix, approved by the FDA in 2006, is a prescription drug to help people quit smoking.  Chantix blocks receptors in the brain that are stimulated by nicotine, reducing a sense of well being brought about by cigarette smoking.  After being on the market for a short period, patients and doctors reported that Chantix was linked to depression, suicide and other abnormal behavior.  The FDA investigated these reports linking Chantix to death, hallucinations, nightmares, and violent shifts in behavior.  The FDA Safety Committee ordered Pfizer, the manufacturer of Chantix, to add information to the drug’s warning label about potential psychiatric side effects to make sure users of Chantix are well informed about the drug’s side effects.

FDA Requires a Black Box Warning:

In 2009, the FDA required Pfizer to add a black box warning to caution users about potentially life-threatening side effects of Chantix.  This came after the FDA received 100 reports of Chantix-related suicides and 198 reports of attempted suicide.  Many Chantix suicide lawsuits and other injury claims have been filed against Pfizer in various states and federal courts throughout the United States.  Complaints allege Pfizer, which excluded individuals with depression or a history of mental illness from many clinical trials, failed to adequately research the side effects of its drug before marketing it aggressively as an easy solution to help people stop smoking.  A more recent lawsuit in Canada claims that Pfizer was required to give patients and doctors more warning about the severity of the psychological side effects of Chantix.  This Canadian class action suit claims that Pfizer put profits ahead of public safety.  Chantix Lawyers are continuing to investigate hundreds of other potential cases that are expected to be filed in the coming months.

If you have experienced suicidal thoughts, depression, or any other psychologically related illness while on Chantix, you may be entitled to financial compensation. Chantix Lawsuits are currently being filed across the country.


Susan Ardizzoni, Ph.D. holds a Doctorate in Biology with a major in Neuroscience (medical) and minors in Biochemistry, Physics, and Mathematics with experience in basic and clinical research.  Although the author is not an attorney, this article was sponsored by the law firm of Bernstein Liebhard LLP and constitutes Attorney Advertising.  To learn more about Chantix Lawyers or Chantix Lawsuits please visit www.ConsumerInjuryLawyers.com

Published November 17, 2011 by